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Introduction
Tissue-specific stem cells were thought to be lineage restricted
and therefore only able to differentiate into cell types of the
tissue of origin. However, several recent studies suggest that
this type of stem cell might be able to break the barriers of
germ layer commitment and differentiate in vitro and/or in vivo
into cells of different tissues. For instance, transplanted bone
marrow cells contribute to endothelium (Asahara et al., 1997;
Jackson et al., 2001; Lin et al., 2000; Orlic et al., 2003; Orlic
et al., 2001; Rafii et al., 1994) and skeletal muscle myoblasts
(Ferrari et al., 1998; Gussoni et al., 1999) and acquire
properties of hepatic and biliary duct cells (Lagasse et al.,
2000; Petersen et al., 1999; Theise et al., 2000), lung, gut, and
skin epithelia (Krause et al., 2001) as well as neuroectodermal
cells (Brazelton et al., 2000; Mezey et al., 2000; Mezey et al.,
2003). Buzanska and colleagues reported recently that human
umbilical cord blood-derived cells attain neuronal and glial
features in vitro (Buzanska et al., 2002). Furthermore, neural
stem cells (NSCs) may repopulate the hematopoietic system
(Bjornson et al., 1999; Shih et al., 2002; Shih et al., 2001), and
muscle cells may differentiate into hematopoietic cells
(Jackson et al., 1999).
Mesodermal stromal cells (MSCs) derived from bone
marrow cell suspensions by their selective attachment to tissue
culture plastic can be expanded efficiently (Friedenstein et al.,
1976; Reyes et al., 2001; Sekiya et al., 2002). MSCs are
capable of differentiating into many mesodermal tissues,
including bone, cartilage, fat, and muscle (Friedenstein et al.,
1976; Orlic et al., 2001; Prockop, 1997; Reyes et al., 2001;
Sekiya et al., 2002). In addition, these cells were reported to
differentiate in vitro and in vivo into cells expressing neuronal
and glial markers (Sanchez-Ramos et al., 2000; Woodbury et
al., 2000; Zhao et al., 2002). Jiang and co-workers recently
demonstrated a rare multipotent adult progenitor cell (MAPC)
within MSC cultures from rodent bone marrow (Jiang et al.,
2002a; Jiang et al., 2002b). This cell type differentiates not
only into mesenchymal lineage cells but also into endothelium
and endoderm. Mouse MAPCs injected in the blastocyst
contribute to most if not all somatic cell lineages including
brain (Jiang et al., 2002a). Furthermore, mouse MAPCs can
also be induced to differentiate in vitro using a co-culture
system with astrocytes into cells with biochemical, anatomical,
and electrophysiological characteristics of neuronal cells
(Jiang et al., 2003). However, in vitro conversion of human
MSCs into clonogenic undifferentiated hNSCs, which can be
proliferated and subsequently differentiated into all major cell
lineages of the brain, such as neurons, astroglia and
oligodendroglia has not been reported. This immature hNSC
population would be more suitable for neuroregenerative
strategies using transplantation than fully differentiated neural
cells because terminal differentiated neuronal cells are well
known to survive detachment and subsequent transplantation
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Clonogenic neural stem cells (NSCs) are self-renewing cells
that maintain the capacity to differentiate into brain-
specific cell types, and may also replace or repair diseased
brain tissue. NSCs can be directly isolated from fetal or
adult nervous tissue, or derived from embryonic stem cells.
Here, we describe the efficient conversion of human adult
bone marrow stromal cells (hMSC) into a neural stem cell-
like population (hmNSC, for human marrow-derived NSC-
like cells). These cells grow in neurosphere-like structures,
express high levels of early neuroectodermal markers, such
as the proneural genes NeuroD1, Neurog2, MSl1 as well as
otx1 and nestin, but lose the characteristics of mesodermal
stromal cells. In the presence of selected growth factors,
hmNSCs can be differentiated into the three main neural
phenotypes: astroglia, oligodendroglia and neurons. Clonal
analysis demonstrates that individual hmNSCs are
multipotent and retain the capacity to generate both glia
and neurons. Our cell culture system provides a powerful
tool for investigating the molecular mechanisms of neural
differentiation in adult human NSCs. hmNSCs may
therefore ultimately help to treat acute and chronic
neurodegenerative diseases.
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procedures poorly (Bjorklund and Lindvall, 2000; Carvey et
al., 2001; Kim et al., 2002b; Pluchino et al., 2003). We show
here that comparable to embryonic stem (ES) cells, adult
human MSCs can be converted into a clonogenic neural stem
cell-like population (hmNSC, for human marrow-derived
NSC-like cells) growing in neurosphere-like structures, which
can be differentiated in vitro into cells with morphological and
functional characteristics of neuronal, astroglial and
oligodendroglial cells.
Materials and Methods
Cell culture
Adult human bone marrow was harvested from routine surgical
procedures (pelvic osteotomies; 4 samples; age 18-35 years)
following informed consent and in accordance with the terms of the
ethics committee of the University of Ulm. hMSC were isolated and
cultured as described earlier (Fickert et al., 2003; Fiedler et al., 2002).
Cells were passaged once a week. The hMSC phenotype was
confirmed by FACS analysis with CD9, CD90, CD105, and CD166
(positive), as well as CD14, CD34, and CD45 (negative), and by the
potential to differentiate in osteoblasts, chondrocytes and adipocytes.
After passage 2-10 (» 10-50 population doublings) conversion of
hMSC into neurosphere-like structures was initiated. Specifically,
cells were dissociated with 0.05% trypsin/0.04% EDTA and plated on
low-attachment plastic tissue culture flasks (Nalge Nunc International,
Rochester, NY, USA) at a concentration of 1-2 · 105 cells/cm2 in P4-
8F medium (AthenaES, Baltimore, MD) supplemented with 20 ng/ml
of both epidermal growth factor (EGF) and fibroblast growth factor-
2 (FGF-2; both from Sigma, St Louis, MO) at 5% CO2, 92% N2 and
3% O2. After 10-20 days, sphere formation could be observed. These
neurosphere-like structures were expanded for an additional 2-10
weeks (2-4 passages; » 5-30 population doublings) before glial or
neuronal differentiation was started. The medium was changed once
a week and growth factors were added twice a week. Induction of
terminal neural differentiation was initiated by plating the cells on
poly-L-lysine coated glass cover slips at a concentration of 1.5-
2.0· 105 cells/cm2 in Neurobasal® medium (Gibco, Tulsa, OK)
supplemented with 0.5 m M all-trans-retinoic acid (Sigma), 1% FCS,
5% horse serum, 1% N2 supplement and 1% penicillin/streptomycin
(all from Gibco). 10 ng/ml rh-PDGF-BB was then added for glial
induction (R&D Systems, Minneapolis, MN) or 10 ng/ml rh-BDNF
for neuronal induction (Promega, Madison, WI). Cells were
differentiated for 10-14 days.
Clonal analysis of hmNSCs
Clonal analysis was performed according to Uchida and co-workers
(Uchida et al., 2000). In brief, hmNSCs were serially diluted into
hmNSC expansion medium in 96-well plates. Only single cells were
expanded by supplementing the medium to 50% with filtered medium
conditioned for 48 hours on hmNSC and containing growth factors.
Cells were expanded for 3-6 weeks and further processed as described
above for hmNSC using the neuronal induction protocol.
Osteogenic differentiation of hmNSCs
In order to differentiate hMSCs and hmNSCs into osteoblasts, we
used standard protocols described earlier (Fiedler et al., 2002; Reyes
et al., 2001). We used both cell types from passage 6-10. Briefly,
osteogenic differentiation was induced by plating the cells at 2 · 104
cells/cm2 in DMEM medium containing 10% FCS, 1% glutamine and
1% penicillin/streptomycin supplemented with 0.1 m M
dexamethasone, 50 mg/ml ascorbic acid, and 2.16 mg/ml b -
glycerophosphate (all from Sigma, St Louis, MO). Cells were cultured
for 14 days and medium was changed twice a week.
Flow cytometry
hMSC and hmNSC were treated with trypsin-EDTA (Gibco) and
washed with PBS. Dead cells were excluded from analysis by
forward-scatter gating. Samples were analyzed using FACSCalibur
flow cytometer and Cellquest software (both from Becton Dickinson,
Franklin Lakes, NJ). A minimum of 12,000 events was acquired for
each sample.
Immunocytochemistry
Cells were fixed in 4% paraformaldehyde in PBS.
Immunocytochemistry was carried out using standard protocols. Cell
nuclei were counterstained with 4,6-diamidino-2-phenylindole
(DAPI). Antibodies and dilutions were as follows: TH monoclonal,
1:1000; b -tubulin III monoclonal, 1:1000; fibronectin monoclonal,
1:400 (all from Sigma); MAP2ab monoclonal, 1:300 and GFAP
monoclonal, 1:1000 (both Pharmingen, San Diego, CA); GalC
monoclonal, 1:750; GFAP polyclonal, 1:1000; nestin polyclonal,
1:500 (all from Chemicon International, Temecula, USA).
Fluorescence labeled secondary antibodies (Jackson, West Grove, PA)
were then applied. For visualizing osteoblasts, the cultures were
analyzed by enzymatic testing for alkaline phosphatase (AP) activity
according to standard protocols using an AP staining kit (Sigma)
(Fiedler et al., 2002).
RNA extraction, RT-PCR and quantitative real-time RT-PCR
analysis
Total cellular RNA was extracted from hMSCs, hmNSCs and
terminally differentiated hmNSCs (neuronal induction medium) using
RNAeasy total RNA purification kit followed by treatment with
RNase-free DNase (Qiagen, Hilden, Germany). RT-PCR reactions
were performed essentially as described previously (Fiedler et al.,
2002). Primer sequences (forward, reverse) and lengths of the
amplified products were as follows: AP (5 ¢ -ACC TCG TTG ACA
CCT GGA AG-3 ¢ , 5¢ -CCA CCA TCT CGG AGA GTG AC-3 ¢ , 189);
c-fos (5¢ -AGC TCT GTG GCC ATG GGC CCC-3 ¢ , 5¢ -AGA CAG
ACC AAC TAG AAG ATG A-3 ¢ , 457); GAPDH (5 ¢ -CGG AGT CAA
CGG ATT TGG TCG TAT-3 ¢ , 5¢ -AGC CTT CTC CAT GGT TGG
TGA AGA C-3¢ , 188); RUNX2 (5 ¢ -TAC CAG ACC GAG ACC AAC
AGA G-3 ¢ , 5¢ -CAC CAC CGG GTC ACG TCG C-3 ¢ , 239); SOX9
(5¢ -CTA CGA CTG GAC GCT GGT GC- 3 ¢ , 5¢ -CGA TGT CCA CGT
CGC GGA AG-3 ¢ , 234). Quantitative real-time one step RT-PCR was
carried out using the LightCycler® System (Roche, Mannheim,
Germany), and amplification was monitored and analyzed by
measuring the binding of the fluorescent dye SYBR Green I to double-
stranded DNA. 1 m l total RNA was reverse transcribed and
subsequently amplified using QuantiTect SYBR Green RT-PCR
Master mix (Qiagen) and 0.5 m M each of the sense and antisense
primers. Tenfold dilutions of total RNA were used as external
standards. Standards and samples were simultaneously amplified.
After amplification, melting curves of the RT-PCR products were
acquired to demonstrate product specificity. Results are expressed
relative to the housekeeping gene HMBS (hydroxymethylbilane
synthase). Primer sequences, lengths of the amplified products and
melting analyses are summarized in Table 1.
Electrophysiology
Cells were investigated for membrane currents between days 10 and
20 after differentiation using the standard whole-cell patch-clamp
technique with an EPC-7 amplifier (List Electronics, Heidelberg,
Germany) and pClamp data acquisition (Axon Instruments) as
Journal of Cell Science 117 (19)
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Table 1. Primers used for quantitative real-time RT-PCR
Gene (Protein) Sequence (forward; reverse)
Product length
(bp)
Melting point
analysis*
FN1 (Fibronectin) 5’-GAG ATC AGT GGG ATA AGC AGC A-3’
5’-CCT CTT CAT GAC GCT TGT GGA-3’ 150
GFAP (GFAP) 5’-GAG GCG GCC AGT TAT CAG GA-3’
5’-GTT CTC CTC GCC CTC TAG CA-3’
168
HMBS (Hydroxymethylbilane synthase) 5’-TCG GGG AAA CCT CAA CAC C-3’
5’-CCT GGC CCA CAG CAT ACA T-3’
155
MBP (Myelin basic protein) 5’-CGG CAA GAA CTG CTC ACT ATG-3’
5’-GTG CGA GGC GTC ACA ATG–3’
106
MSI1 (Musashi 1) 5’-GCC CAA GAT GGT GAC TCG-3’
5’-ATG GCG TCG TCC ACC TTC-3’
114
NeuroD1 (Neurogenic differentiation 1) 5’-CGC TGG AGC CCT TCT TTG-3’
5’-GCG GAC GGT TCG TGT TTG-3’
118
Neurog2 (Neurogenin 2) 5’-CGC ATC AAG AAG ACC CGT AG-3’
5’-GTG AGT GCC CAG ATG TAG TTG TG-3’
173
NES (Nestin) 5’-TGG CTC AGA GGA AGA GTC TGA-3’
5’-TCC CCC ATT TAC ATG CTG TGA-3’
148
NTRK1 (Neurotrophic tyrosine kinase, receptor,
type 1)
5’-CTA CAG CAC CGA CTA TTA CCG–3’
5’-CGA TTG CCT CCG TGT TG–3’
128
OCT-4 (Octomer-binding transcription factor 4) 5’-GTA TTC AGC CAA ACG ACC ATC-3’
5’-CTG GTT CGC TTT CTC TTT CG-3’ 176
OTX1 (Orthodenticle homolog 1) 5’-CAC TAA CTG GCG TGT TTC TGC-3’
5’-AGG CGT GGA GCA AAA TCG-3’
121
SNCA (α-Synuclein) 5’-AGG ACT TTC AAA GGC CAA GG-3’
5’-TCC TCC AAC ATT TGT CAC TTG C-3’
187
SOX1 (Sex determining region Y-box 1) 5’-GCC CAG GAG AAC CCC AAG-3’
5’-CGT CTT GGT CTT GCG GC-3’
177
TH
(Tyrosine hydroxylase)
5’-AGC TCC TGA GCT TGT CCT TG-3’
5’-TGT CCA CGC TGT ACT GGT TC-3’
142
TUBB4/III (β-Tubulin III) 5’-AGT GAT GAG CAT GGC ATC GA-3’
5’-AGG CAG TCG CAG TTT TCA CA-3’
317
*x-axis represents temperature (from 68-92°C in 4°C steps), y-axis indicates fluorescence [d(F1)dT].
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described previously (Labarca et al., 2001; Storch et al., 2003). We
added 10% FCS 3-5 days prior to patch-clamp experiments for better
sealing. Extracellular solution contained 100 mM NaCl, 54 mM KCl,
2 mM CaCl2, 2 mM MgCl2, 10 mM HEPES, 10 mM D-Glucose. The
pipette solution was 130 mM KCl, 0.5 mM CaCl2, 2 mM MgCl2, 5
mM EGTA, 10 mM HEPES, 3 mM Na-ATP. Using these solutions,
borosilicate pipettes had resistances of 3-4 M W . Data were analyzed
using pClamp 8.0, Microsoft Excel 97 and Origin 5.0 software.
Reverse-phase HPLC with electrochemical detection
For determination of dopamine production and release, media were
supplemented with 100 m M tetrahydrobiopterin and 200 m M ascorbate
3 days prior to medium harvest. Dopamine levels were determined in
medium and extracellular buffer stabilized with EGTA/glutathione
solution as reported previously (Storch et al., 2001), and stored at 
- 80° C until analysis. Aluminum absorption and HPLC analysis of
dopamine have been described (Storch et al., 2001).
Cell counting and statistics
For quantification of the percentage of cells producing a given marker,
in any given experiments the number of positive cells of the whole
well surface was determined relative to the total number of DAPI-
labeled nuclei. In a typical experiment, a total of 500-1000 cells were
counted per marker. Statistical comparisons were made by Dunnett’s
t-test. If data were not normally distributed, a non-parametric test
(Mann-Whitney U-test) was used for comparisons of results. All data
are expressed as mean±s.e.m.
Results
Characterization of undifferentiated hMSCs
Bright staining was seen with antibodies against the
mesodermal marker fibronectin in all cells (Fig. 1A), but only
4±3% (n=3) of cells were slightly positive for nestin (Fig. 1A).
No staining was observed against markers of mature
neuroectodermal cell types, such as MAP2ab, TH, GFAP and
GalC (data not shown). Flow cytometry revealed that hMSC
were CD9+/low, CD15–, CD34–, CD45–, CD90+, CD166+,
CD133– (Fig. 2). In quantitative RT-PCR, hMSCs expressed
high levels of FN1, SOX1 and NTRK1, significant levels of
OCT-4, but very low levels of Neurog2, NES, GFAP and
TUBB4/III. hMSCs did not significantly express MSl1, OTX1,
NeuroD1, MBP, SNCA and TH (Fig. 3; for complete names of
genes and encoded proteins, refer to Table 1). hMSCs
proliferated for at least 10 weeks without changing their
morphology and phenotype (doubling time: 1.5 days; » 50
population doublings).
Culture conditions for conversion of hMSCs into
neuroprogenitor-like cells
To convert adult hMSCs into cells with characteristics of
NSCs, we detached hMSCs after 2-10 passages ( » 10-50
population doublings) and cultured them in uncoated flasks in
serum-free P4-8F medium supplemented with EGF and FGF-
Journal of Cell Science 117 (19)
Fig. 1. Characteristics of adult human mesodermal stromal cells (hMSC) and human marrow-derived neural stem cell-like cells (hmNSC)
during expansion. (A) Morphology, fibronectin and nestin expression of hMSC (left panels) and hmNSC (right panels). All hMSCs express
high levels of fibronectin, but only 4±3% of cells express very low levels of the NSC marker nestin, whereas some hmNSCs express low levels
of fibronectin, but nearly all cells express high levels of nestin. Nuclei are counterstained with DAPI (blue). Bar, 100 m m. (B) Representative
sequence of phase-contrast photomicrographs of hmNSCs 1, 5, 12 and 21 days after conversion from hMSCs. A growth curve of hmNSCs
revealed by enumerating the cells at each time point under a hemocytometer is also shown (n=5; calculated doubling time 2.6 days). Bar, 50
m m.
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2. The cells did not adhere to the surface of tissue culture
flasks. One third (37±17%, n=5) of hMSCs died after 3 days,
but after 10-14 days, the remaining cells formed small spheres
of floating cells (Fig. 1A,B). hmNSCs proliferated with an
estimated doubling time of 2.6 days in vitro for at least up to
10 weeks ( » 5-30 population doublings; Fig. 1B) without
changing morphology or phenotype. Immunocytochemistry
showed that 87±2% of hmNSCs expressed high levels of
nestin, but only a few cells expressed low levels of fibronectin
(Fig. 1A). No staining was seen using antibodies against
MAP2ab, GFAP and GalC. The phenotype of these hmNSCs
was CD15, CD34, CD45, CD133 and CD166 negative;
hmNSCs expressed low levels of CD9, but higher levels of
CD90 (Fig. 2). Notably, CD133 expression was only detected
on a small hmNSC subset (<1%), consistent with previous
reports on neural progenitors (Uchida et al., 2000; Vogel et al.,
2003). Quantitative analysis of FN1 mRNA showed similar
levels in hmNSCs compared to those in hMSCs, but
significantly decreased levels of SOX1, OCT-4 and NTRK1
(Fig. 3). On the other hand, quantitative RT-PCR of hmNSC
demonstrated acquisition of neuroectodermal transcripts. In
hmNSC, mRNA encoding for otx1, neuroD1, neurogenin2,
musashi1 and nestin could be detected at levels between 4.5-
and 77.1-fold those seen in hMSCs (Fig. 3B). Similar to
hMSCs and as expected for NSCs, the mRNA levels for marker
genes of mature neural cell types, such as GFAP, MBP,
TUBB4/III, SNCA and TH, were undetectable or very low (Fig.
3B).
Neuronal differentiation of hmNSCs
For terminal differentiation in vitro, we used a neuronal and a
glial induction protocol, by plating the cells onto poly-L-lysine
and adding cytokines and growth factors known to induce
differentiation of NSCs into mature neuronal or glial cells.
Differentiation into neuronal cells required plating of hmNSCs
in medium without EGF and FGF-2, but with brain-derived
neurotrophic factor (BDNF) and retinoic acid (neuronal
induction medium). Ten to fourteen days after plating,
quantitative mRNA analysis revealed that the expression of
FN1 as well as the proneural genes SOX1, OTX1, NeuroD1 and
Neurog2 was down-regulated during terminal neuronal
differentiation of hmNSCs (Fig. 3B). In contrast, marker
mRNA levels of mature neural cell types (GFAP, MBP,
TUBB4/III, SNCA and TH) were significantly increased (Fig.
3B). No changes were seen in the expression level of OCT-4
and NTRK1. Consistently, we obtained 42±6% of hmNSCs
with early neuronal characteristics (b -tubulin III expression)
and 6±2% expressing the marker molecule for mature neurons
(MAP2ab) but only 13±4% of cells with GFAP expression and
astroglial morphology (Fig. 4A,B). MAP2ab and GFAP were
never found in the same cell. Interestingly, in these cultures
11±7% of cells expressed the catecholaminergic marker TH
(n=3), which is the rate-limiting enzyme for dopamine
synthesis. To test whether these TH-positive cells displayed the
ability to synthesize dopamine and release it in response to
membrane depolarization, media of hMSC and hmNSCs were
harvested before and after terminal differentiation and assayed
by HPLC. Dopamine was not detectable in the media of
hMSCs and undifferentiated hmNSCs with or without KCl
depolarization (data not shown). In contrast, when media of in
vitro differentiated hmNSCs (day 14) were assayed, total
dopamine concentrations were 108±83 pg/ml (Fig. 5A,B).
Following these results dopamine release following membrane
depolarisation was measured. After treatment of differentiated
hmNSCs with 56 mM KCl, the released dopamine in the media
was 709±269 pg/ml (Fig. 5A,B). Differentiation of hMSCs
using the neuronal induction protocol produced neither mature
MAP2ab+ neurons nor TH+/dopamine producing cells (n=5),
and did not lead to an up-regulation of TUBB4/III or GFAP
gene expression (data not shown). Patch-clamp experiments to
demonstrate neuronal characteristics in these cells were not
successful as addition of 10% FCS was necessary to obtain
sufficiently high seal resistances, but this led to an extensive
overgrowth of glial cells.
Glial differentiation of hmNSCs
Using the glial induction medium containing platelet-derived
growth factor (PDGF-BB) and retinoic acid for 10-14 days,
45±4% of hmNSCs acquired morphologic and phenotypic
characteristics of astrocytes (GFAP+), 27±5% acquired
Fig. 2. Flow cytometry of hMSCs (upper panels) and hmNSCs (lower panels) cultured for 10-50 and 5-30 population doublings, respectively.
Cells were labeled with fluorescence-coupled antibodies against CD9, CD15, CD34, CD45, CD90, CD133, CD166 or immunoglobulin isotype
control antibodies. Cells were analyzed using a FACSCalibur flow cytometer. Black line, control immunoglobulin; red line, specific antibody.
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characteristics of oligodendrocytes [galactocerebrosidase
(GalC) +], whereas only a few cells exhibited the early neuronal
marker class III b -tubulin (Fig. 4B). There were no relevant
morphological differences between cells differentiated with the
neuronal and the glial induction protocol, respectively. No
mature MAP2ab+ neurons could be detected.
Electrophysiological analysis of hmNSCs, that were
differentiated using the glial induction protocol, revealed that
about 40% of cells (19 out of 47 recorded cells) showed a
sustained outward current of a few hundred pA up to 6 nA.
Journal of Cell Science 117 (19)
Fig. 3. Quantitative transcription profile of hMSC, hmNSCs and terminal differentiated hmNSCs into glial and neuronal cell types.
(A) Representative real-time RT-PCR analysis using the LightCycler® technique. Plot of the fluorescence versus the cycle number obtained
from SYBR Green detection of serially diluted FN1 mRNA (encoding fibronectin) (left). The horizontal line represents the position of the
threshold. The standard curve obtained by plotting cycle number of crossing points versus dilution factor is shown (center), in addition to
melting curve analysis showing the specificity of the amplified PCR product (right). (B) Quantitative real-time RT-PCR analyses of mesodermal
genes (FN1), proneural genes (SOX1, OTX1, NeuroD1, Neurog2, MSl1), NSC marker genes (NES), glial genes (GFAP, MBP) and neuronal
genes (TUBB4/III, SNCA, NTRK1, TH) as well as OCT-4 as a marker for pluripotency in hMSC, hmNSCs and differentiated hmNSCs,
respectively, by the neuronal induction protocol for 14 days. Expression levels are expressed relative to the housekeeping gene HMBS
(hydroxymethylbilane synthase). For primers, complete names of genes and melting curve analyses demonstrating the specificity of amplified
PCR products see Table 1. #, P<0.05; ##, P<0.01 when compared to mRNA levels in hMSCs; +, P<0.05; ++, P<0.01 when compared to mRNA
levels in hmNSCs.
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These currents showed a voltage-dependence and kinetics
characteristic for delayed rectifier K+ channels (Fig. 5C). In a
few cells, we could identify small inward currents with voltage
dependence and kinetics typical for voltage-activated Na+
channels (Fig. 5D).
hmNSCs are clonogenic multipotent progenitor cells
To determine whether individual hmNSCs could generate both
neurons and glia, juvenile sphere-like structures were
dissociated and individual cells were isolated by limiting
dilution into ultra low attachment multi-well plates; single cells
were cultured in hmNSC expansion medium for 3 to 6 weeks.
After this period 11% of the single cells proliferated to
generate neurosphere-like structures (Fig. 4C). Clonal cells
were then differentiated for 10 days. Double immunostaining
revealed that differentiation capacities were very variable
between cell clones with 40±39% (range: 0 to 100%) of
individual cells acquiring morphologic and phenotypic
characteristics of astrocytes (GFAP+) and 26±27% (0-60%)
characteristics of neurons (b -tubulin III+) (Fig. 4C); 28% of the
clones showed only one of the investigated cell types.
hmNSC lose their capacity to differentiate into
mesodermal lineages
To determine whether hmNSCs were still able to differentiate
into mesenchymal cell types in vitro, we compared the ability
of hMSCs and hmNSCs to differentiate into osteoblasts using
standard protocols and high density cultures (Fiedler et al.,
2002; Reyes et al., 2001). After 14 days, 57±5% of hMSCs
acquired morphologic and phenotypic characteristics of
osteoblasts, whereas only 17±5% of hmNSCs expressed
alkaline phosphatase (AP)+ without displaying typical
morphology of osteoblasts (Fig. 6A,B; n=3; P<0.01, t-test).
Consistently, expression levels of AP and runt-related
transcription factor 2 (RUNX2) as osteogenic markers, SOX9
as a mesodermal (chrondogenic/osteogenic) marker (Healy et
al., 1999) and the transcription factor c-fos were very low or
absent in osteogenic differentiated hmNSCs (Fig. 6C).
Discussion
The central finding of this study is that cells with major
characteristics of NSCs can be efficiently generated from
human MSCs obtained from adult bone marrow, in a similar
way as NSCs are derived from ES cells (Bain et al., 1995; Lee
et al., 2000). These bone marrow-derived NSCs were cultured
in neurosphere-like structures using a technique similar to
those used for isolation and propagation of NSCs (Carvey et
al., 2001; Cattaneo and McKay, 1990; Johansson et al., 1999;
Reynolds and Weiss, 1992; Storch et al., 2001; Storch and
Schwarz, 2002; Uchida et al., 2000). The phenotype of these
cells is similar to that of human neural progenitor cells derived
from fetal forebrain (Uchida et al., 2000; Vogel et al., 2003),
but different from that of hMSC (Fickert et al., 2003; Fiedler
et al., 2002; Vogel et al., 2003). Our hmNSCs are clonogenic,
self-renewing cells that maintain the capacity to differentiate
into mature functional brain-specific cell types, while losing
mesodermal characteristics. The differentiation capacity of
hmNSCs is similar to that of hNSCs derived from fetal or adult
Fig. 4. In vitro differentiation of marrow-derived neurosphere-like
structures into astroglial, oligodendroglial and neuronal cell types.
hmNSCs were differentiated after 5-30 population doublings using
the glial induction or the neuronal induction protocol on poly-L-
lysine coated coverslips for 14 days. (A) hmNSCs differentiated
using the neuronal induction medium were stained for markers for
astrocytes (GFAP), oligodendrocytes (GalC), neurons ( b -tubulin-III,
MAP2ab), or catecholaminergic cells (TH). Nuclei are
counterstained with DAPI (blue). Bars, 50 m m. (B) Quantification of
14-day cultures of hmNSCs differentiated with the glial and the
neuronal induction protocols. Data shown are mean±s.e.m. from at
least three independent hMSC preparations. *, P<0.05; **, P<0.01
when compared to the percentage of positive cells in the glial
induction protocol. (C) Clonal expansion from single hmNSCs. Six
representative photomicrographs of neurosphere-like structures
derived from single hmNSCs (left). Bar, 50 m m. Differentiation
capacity of clonally derived neurosphere-like structures (right panel).
Progeny of single cell-derived neurosphere-like structures can be
differentiated into neurons (b -tubulin III+, green) and astrocytes
(GFAP+, red). Nuclei are counterstained with DAPI (blue). Bar, 30
m m.
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brain (Fricker et al., 1999; Johansson et al., 1999; Storch et al.,
2001; Uchida et al., 2000; Westerlund et al., 2003).
Oct-4, a member of the POU family of transcription factors,
is characteristically expressed in embryonic cells and
necessary for their pluripotency (Pesce and Scholer, 2000).
Recently, Pochampally and co-workers reported the expression
of the OCT-4 gene in hMSCs with higher expression in cells
cultured in serum-free medium (Pochampally et al., 2004). We
also demonstrated Oct-4 expression in our initial hMSC
population suggesting that these cultures contain pluripotent
progenitors, which might be related to pluripotent MAPCs
(Jiang et al., 2003; Jiang et al., 2002a). Consistent with the
more restricted (neuroectodermal) differentiation capacity of
hmNSCs the expression level of Oct-4 was reduced after the
conversion of hMSCs into hmNSCs. A large body of
knowledge exists on lineage determination in NSCs, because
unlike many types of stem cells, NSCs undergo self-renewal
and multilineage differentiation in culture. SOXB1
transcription factors, including the three closely related genes
SOX1, SOX2 and SOX3, universally mark neural progenitor and
stem cells throughout the vertebrate CNS (Bylund et al., 2003;
Pevny et al., 1998; Uwanogho et al., 1995). Recent data further
suggest that Sox1-3 signaling is both necessary and sufficient
to maintain pan-neural properties of undifferentiated NSCs and
therefore generation of neuronal cells from NSCs depends on
the inhibition of Sox1-3 expression (Bylund et al., 2003;
Graham et al., 2003). Consistently, in undifferentiated
hmNSCs we detected significant SOX1 gene expression with
decreasing mRNA levels during terminal differentiation of
hmNSCs. The highest level of SOX1 gene expression was
found in hMSCs, suggesting a multipotency of this progenitor
cell type including a neuroectodermal potential. These data are
in line with results by Woodbury and co-workers showing
expression of some early and late neuroectodermal genes in
hMSCs (Woodbury et al., 2002).
Proneural genes, which encode transcription factors of the
basic helix-loop-helix (bHLH) class such as neuroD1 and
neurogenin2, are both necessary and sufficient to initiate the
development of neural lineages and to promote the generation
of progenitors that are committed to neural differentiation
(Bertrand et al., 2002; Bylund et al., 2003; Graham et al.,
2003). Proneural genes are mostly expressed in
neuroprogenitor cells including NSCs in early
neuroectodermal tissues (Franklin et al., 2001; Nieto et al.,
2001; Simmons et al., 2001). The exact mechanisms of action
of proneural genes are only partially understood, but one major
effect is the inhibition of Sox1-3 expression (Bylund et al.,
2003; Graham et al., 2003). In hMSCs with high Sox1
Journal of Cell Science 117 (19)
Fig. 5. Functional properties of terminal
differentiated hmNSC. (A-B) Dopamine
production and release was measured in hmNSCs
differentiated using the neuronal induction protocol
for 14 days. (A) Representative chromatograms of
HPLC-ECD determination of dopamine in medium
conditioned for 3 days (left) and extracellular
buffer with 56 mM KCl conditioned for 45 minutes
(right). (B) Quantification of dopamine in medium
conditioned for 3 days (left), in extracellular buffer
conditioned for 45 minutes (center), and in
extracellular buffer with 56 mM KCl conditioned
for 45 minutes (right). # , P<0.05 when compared
to extracellular buffer dopamine levels (paired t-
test). (C,D) Electrophysiological recordings on
hmNSCs differentiated using the glial induction
protocol. For voltage-clamp measurements, cells
were held at –80 mV and hyperpolarized or
depolarized in 10 mV steps between –160 and +70
mV. (C) Example of a sustained outward current
shown without and with (inset) leak subtraction
using a –P/4 protocol (left). Current-voltage
relationship of the normalized outward currents
recorded with leak subtraction (n=7, right panel).
(D) Example of an inward current without and with
leak subtraction (inset: only currents for
depolarizing steps to –40, –20, 0, 20 and 60 mV
are shown) (left). Peak current-voltage relationship
for the same cell with leak subtraction (right
panel). The line represents a fit to the following
equation: I(V)/Imax= g(V–Vrev)/1+exp[(V–V0.5)/kV],
where I (Imax) is the (maximum) membrane
current; g, the maximum conductance; V, the
applied voltage; Vrev, the reversal potential for Na+;
V0.5, the potential of half-maximal activation and
kV, a slope factor.
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expression, the levels of proneural genes are absent or very low,
but conversion into hmNSC with lower levels of Sox1 leads to
significant up-regulation of the expression of all investigated
proneural genes. Terminal differentiation of hmNSCs resulted
in down-regulation of proneural genes leading to very low or
absent expression levels.
The Otx homeobox gene OTX1 is widely and exclusively
expressed at early stages of neuroectoderm differentiation
(Acampora et al., 2001; Simeone, 1998). In contrast to hMSCs,
hmNSCs express significant levels of OTX1, which nearly
disappear after terminal differentiation of these cells into
neuronal/glial cells. The RNA-binding protein musashi1 is
involved in post-transcriptional gene regulation in
neuroprogenitors and/or NSCs and is used as a marker for those
cell types (Kaneko et al., 2000). Consistently, musashi1 is not
expressed in hMSCs, but up-regulated during the conversion
of hMSCs into hmNSCs. NSCs can be further defined by the
presence of the intermediate filament protein nestin (Cattaneo
and McKay, 1990; Dahlstrand et al., 1995; Lendahl et al.,
1990), which is also found in young neurons, reactive glial
cells and ependymal cells (Johansson et al., 1999). Taken
together, after the conversion, hmNSCs acquire a specific
expression pattern of early neuroectodermal and/or NSC
marker genes, such as SOXB1 transcription factors, proneural
genes and nestin. However, it is unclear from the present
experiments whether reprogramming of a committed
mesenchymal stem cell (transdifferentiation) or proliferation
and differentiation of a more pluripotent stem cell already
harbored in the hMSC suspension is responsible for the cell
type conversion in our system (Jiang et al., 2002a; Sanchez-
Ramos, 2002).
Further evidence for the stem cell-like nature of hmNSCs
within the adult marrow-derived neurosphere-like aggregates
is the demonstration of clonogenicity of individual cells in the
limiting dilution assay. In the presence of growth
factors/cytokines known to induce glial/neuronal
differentiation in brain-derived NSCs, hmNSCs differentiate in
vitro into all major cell types of the CNS, including mature
neurons expressing MAP2ab. Unfortunately, we have not yet
characterized these neurons electrophysiologically.
Electrophysiological characterization of neurons derived from
human progenitor cells have only been reported in two studies
(Carpenter et al., 2001; Westerlund et al., 2003). However,
Jiang and co-workers showed functional characteristics of
neurons (generation of action potentials, expression of sodium
channels) in neurons derived from MAPCs by using co-
cultures with primary astrocytes (Jiang et al., 2003). These
differentiated mouse multipotent adult progenitor cells also
show a morphological phenotype with expression of TH,
dopamine and dopa-decarboxylase, like dopaminergic neurons
in vitro (Jiang et al., 2003; Jiang et al., 2002a). Jin and
colleagues showed by immunocytochemical techniques that
murine bone marrow cells can be induced to synthesize the
neurotransmitter GABA using similar differentiating factors as
we used in the present study (Jin et al., 2003). However, no
depolarization-dependent release of GABA was shown. Our
differentiated hmNSCs also express TH at both the mRNA and
protein levels, but also produce and release dopamine similar
to functional dopaminergic neurons (Lee et al., 2000; Storch et
al., 2001). Using the glial induction protocol and FCS to
differentiate hmNSCs, we were able to demonstrate
electrophysiological properties typical for developing and adult
glial cells (Bordey and Sontheimer, 2000; Gritti et al., 2000;
Kressin et al., 1995). Consistent with the neuroectodermal
nature of hmNSCs, their mesodermal/osteogenic
differentiation potential is nearly absent. In summary the
differentiation capacity of hmNSCs seems similar to that of
NSCs derived from fetal and adult brain of various species
(Carvey et al., 2001; Cattaneo and McKay, 1990; Kilpatrick
and Bartlett, 1993; Reynolds and Weiss, 1992; Song et al.,
Fig. 6. Osteogenic differentiation ability of both hMSCs and hmNSCs. Both cell types were differentiated after 6-10 passages using the
osteoblast differentiation protocol for 10 days. (A) Differentiated hMSCs (upper panel) and hmNSCs (lower panel) were stained for the
osteogenic marker alkaline phosphatase (AP). Bar, 50 m m. (B) Quantification of 10-day cultures of hMSCs and hmNSCs differentiated into
osteoblasts under normal atmospheric oxygen levels routinely used for osteoblast cultures (21%) and reduced atmospheric oxygen levels used
in our neural culture system (3%). Data shown are mean±s.e.m. from at least three independent cell preparations. *, P<0.05; **, P<0.01 when
compared to the percentage of AP+ cells in hMSCs. (C) Expression of osteogenic and mesodermal marker genes as well as the transcription
factor c-fos in hMSCs and hmNSCs after osteogenic differentiation under 21% (lanes 1, 4) and 3% (lanes 2, 3) atmospheric oxygen levels.
Semiquantitative RT-PCR analysis of AP, runt-related transcription factor 2 (RUNX2), SOX9 and the transcription factor c-fos, as well as
GAPDH (housekeeping gene) was performed in hmNSC (lanes 1 and 2) and hMSC (lanes 3 and 4).
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2002; Uchida et al., 2000). Furthermore, we showed for the
first time, functional properties of neuronal/glial cells
generated from human MSCs.
In a typical experiment, for every 1· 106 hMSCs, we
routinely obtained 1.6 · 108 marrow-derived NSCs, 0.1 · 108
neurons, 0.7· 108 astroglial and 0.4 · 108 oligodendroglial cells.
Considering all parameters of proliferation, cell death and
selective differentiation throughout the multiple conversion
and differentiation steps, at least 7· 107 hmNSCs, or 0.5 · 107
neurons, 3· 107 astroglial and 2· 107 oligodendroglial cells,
respectively, could numerically be produced from one hMSC
harvested from the bone marrow sample. These cell quantities
are sufficient for most transplantation protocols as well as for
extensive characterizations of adult NSCs by molecular
biology or protein biochemistry, such as gene array analysis or
proteomics. Thus, hmNSCs could facilitate understanding the
molecular mechanisms of neural differentiation in adult human
NSCs. In contrast to most previous protocols for the conversion
of MSCs into neuroectodermal cells generating mature
neuronal and/or glial cells attached to the culture surface
(Hofstetter et al., 2002; Jiang et al., 2003; Jiang et al., 2002a;
Kim et al., 2002a; Sanchez-Ramos et al., 2000; Woodbury et
al., 2000), we demonstrate here the possibility to generate
undifferentiated NSCs or premature neural cells from human
origin. Those are commonly used and more suitable for
neurotransplantation compared to fully differentiated neural
cells (Bjorklund and Lindvall, 2000; Carvey et al., 2001; Kim
et al., 2002b; Pluchino et al., 2003), as differentiated neuronal
cells are well known to poorly survive detachment and
subsequent transplantation procedures. Although studies in
animal models of neurodegenerative diseases are needed to
assess the function and safety of hmNSC-derived neural cells
in vivo further, our data show that hmNSC differentiate into
mature neural cells showing functional properties, such as
dopamine production and potassium-dependent release after
neuronal differentiation as well as expression of outward-
rectifying potassium channels and sodium channels in glial
cells. However, future experiments are warranted to define
further functional properties of terminal differentiated
hmNSCs into neuronal and glial cells by using co-culture
methods with astroglial cells (Jiang et al., 2003; Song et al.,
2002) and longer periods of differentiation time to achieve
more mature neurons and glial cells (Westerlund et al., 2003).
Our method provides the means to study autologous
approaches in neurotransplantation using adult human NSCs
derived from bone marrow, an accessible tissue in every
individual.
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